Frontiers in Psychiatry · 2018 · 43 citations · 45 references
MedicineImmunologyPsychiatryInflammationNeuroimmunologyPsychoneuroimmunologyAntipsychotic TherapyCytokine DysregulationMental IllnessNeuroinflammationPsychotic DisordersSchizophrenia Spectrum DisordersBiomarkers Of PsychosisCardiometabolic DiseaseEtiology Of Psychotic DisordersInnate Immune CytokinesPsychoneuroimmune DysregulationQuantification Of AnalytesSchizophrenia ComorbiditySoluble St2
Schizophrenia and treatment of this disorder are often accompanied with metabolic syndrome and cardiovascular issues. Alterations in the serum level of innate immune mediators, such as interleukin-33 (IL-33) and its receptor IL-33R (ST2) and Galectin-3 (Gal-3) were observed in these conditions. Moreover, these parameters are potential prognostic and therapeutic markers. There is also accumulating evidence that these molecules play a role in neuroinflammation. Therefore, in this study we have investigated the serum level of Gal-3, IL-33 and soluble ST2 (sST2) in different stages of schizophrenia. Gal-3 levels were elevated in remission and lower in schizophrenia exacerbation in comparison with controls. Levels of IL-33 and sST2 are higher in schizophrenia exacerbation in comparison with controls and patients in remission. This initial analysis of new markers of neuroinflammation suggested their involvement in schizophrenia pathophysiology and/or cardiometabolic comorbidity.
45
Structural and functional features of central nervous system lymphatic vessels
Antoine Louveau, Igor Smirnov, Timothy Keyes et al. · Nature · 2015 · 4.3K citations
Medicine, Anatomy, Neurobiology +14
IL-33 reduces the development of atherosclerosis
Ashley M. Miller, Damo Xu, Darren L. Asquith et al. · The Journal of Experimental Medicine · 2008 · 636 citations · Full text